Literature DB >> 10805631

Research fundamentals: selection and development of clinical outcome measures.

A J Singer1, H C Thode, J E Hollander.   

Abstract

Clinical outcomes measure patient health or well-being. The choice of an outcome measure for use in a clinical trial or study is complex. It is even more difficult when no appropriate outcome measure exists, necessitating the development of a novel one. The ideal clinical outcome should be credible, comprehensive, sensitive to change, accurate, biologically sensible, and feasible. This paper describes the attributes of clinical outcomes and illustrates how to develop novel outcomes, using as an example the authors' experience in developing a wound cosmesis outcome measure.

Entities:  

Mesh:

Year:  2000        PMID: 10805631     DOI: 10.1111/j.1553-2712.2000.tb02249.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  6 in total

1.  Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change.

Authors:  C O Anyanwu; D F Fiorentino; L Chung; C Dzuong; Y Wang; J Okawa; K Carr; K J Propert; V P Werth
Journal:  Br J Dermatol       Date:  2015-08-11       Impact factor: 9.302

2.  Skin closure with 2-octyl cyanoacrylate and polyester mesh after primary total knee arthroplasty offers superior cosmetic outcomes and patient satisfaction compared to staples: a prospective trial.

Authors:  Kavin Sundaram; Nicolas S Piuzzi; Brendan M Patterson; Kim L Stearns; Viktor E Krebs; Michael A Mont
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-11-05

Review 3.  The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review.

Authors:  S Ahmed; K L Chen; V P Werth
Journal:  Semin Arthritis Rheum       Date:  2020-01-11       Impact factor: 5.532

4.  Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.

Authors:  M Yassaee; D Fiorentino; J Okawa; L Taylor; C Coley; A B Troxel; V P Werth
Journal:  Br J Dermatol       Date:  2009-10-26       Impact factor: 9.302

5.  Measurement of disease severity in cutaneous autoimmune diseases.

Authors:  Cynthia Anyanwu; Jamie Langenhan; Victoria P Werth
Journal:  F1000Prime Rep       Date:  2013-06-03

Review 6.  Development of outcome measures for autoimmune dermatoses.

Authors:  Elizabeth Gaines; Victoria P Werth
Journal:  Arch Dermatol Res       Date:  2007-11-06       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.